They are not instos. They are just nominee accounts for private investors and corporate entities (see top 20 below).
Instos = funds. When they come on board there will be a material re-rating. I think when the 1H22 report gets released and the next 4C it will be too hard to ignore the results. We're in for a very exciting period.
Also, as you can see, the top 20 has been BUYING over the last 12 months which is a bullish sign (except for Carl who also stepped down as a Director)
Fair point on chasing stocks. While I'm not concerned if you buy or not, if you're trying to do a valuation, I'd encourage you to think about the forward view and not what the present valuation is. Around now, it might be fairly valued on what it's done today - we've only had one great quarter of results,
but we've inflected and the best is ahead of us. As I'm sure you know,
any valuation is the present value of future cashflows. If you think that the present share price captures all future cashflows then I'd strongly disagree with that view - but this is HC and diversity of opinion is one reason why I check this forum. GLTAH
(20min delay)